| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |